Publication:
Polymorphisms within the ARNT2 and CX3CR1 Genes Are Associated with the Risk of Developing Invasive Aspergillosis.

dc.contributor.authorLupiañez, C B
dc.contributor.authorMartinez-Bueno, M
dc.contributor.authorSanchez-Maldonado, J M
dc.contributor.authorBadiola, J
dc.contributor.authorCunha, C
dc.contributor.authorSpringer, J
dc.contributor.authorLackner, M
dc.contributor.authorSegura-Catena, J
dc.contributor.authorCanet, L M
dc.contributor.authorAlcazar-Fuoli, L
dc.contributor.authorLopez-Nevot, M A
dc.contributor.authorFianchi, L
dc.contributor.authorAguado, J M
dc.contributor.authorPagano, L
dc.contributor.authorLopez-Fernandez, E
dc.contributor.authorAlarcon-Riquelme, M
dc.contributor.authorPotenza, L
dc.contributor.authorGonçalves, S M
dc.contributor.authorLuppi, M
dc.contributor.authorMoratalla, L
dc.contributor.authorSolano, C
dc.contributor.authorSampedro, A
dc.contributor.authorGonzalez-Sierra, P
dc.contributor.authorCuenca-Estrella, M
dc.contributor.authorLagrou, K
dc.contributor.authorMaertens, J A
dc.contributor.authorLass-Flörl, C
dc.contributor.authorEinsele, H
dc.contributor.authorVazquez, L
dc.contributor.authorLoeffler, J
dc.contributor.authorRíos-Tamayo, R
dc.contributor.authorCarvalho, A
dc.contributor.authorJurado, M
dc.contributor.authorSainz, J
dc.contributor.funderFondo de Investigaciones Sanitarias (Madrid, Spain)
dc.contributor.funderERA-NET PathoGenoMics
dc.contributor.funderCollaborative Research Center/Transregio 124 FungiNet, the Northern Portugal Regional Operational Program
dc.contributor.groupPCRAGA Study Group
dc.date.accessioned2023-02-08T14:39:44Z
dc.date.available2023-02-08T14:39:44Z
dc.date.issued2020-01-10
dc.description.abstractInvasive aspergillosis (IA) is a life-threatening infection that affects an increasing number of patients undergoing chemotherapy or allo-transplantation, and recent studies have shown that genetic factors contribute to disease susceptibility. In this two-stage, population-based, case-control study, we evaluated whether 7 potentially functional single nucleotide polymorphisms (SNPs) within the ARNT2 and CX3CR1 genes influence the risk of IA in high-risk hematological patients. We genotyped selected SNPs in a cohort of 500 hematological patients (103 of those had been diagnosed with proven or probable IA), and we evaluated their association with the risk of developing IA. The association of the most interesting markers of IA risk was then validated in a replication population, including 474 subjects (94 IA and 380 non-IA patients). Functional experiments were also performed to confirm the biological relevance of the most interesting markers. The meta-analysis of both populations showed that carriers of the ARNT2rs1374213G, CX3CR1rs7631529A, and CX3CR1rs9823718G alleles (where the RefSeq identifier appears as a subscript) had a significantly increased risk of developing IA according to a log-additive model (P value from the meta-analysis [PMeta] = 9.8 · 10-5, PMeta = 1.5 · 10-4, and PMeta =7.9 · 10-5, respectively). Haplotype analysis also confirmed the association of the CX3CR1 haplotype with AG CGG with an increased risk of IA (P = 4.0 · 10-4). Mechanistically, we observed that monocyte-derived macrophages (MDM) from subjects carrying the ARNTR2rs1374213G allele or the GG genotype showed a significantly impaired fungicidal activity but that MDM from carriers of the ARNT2rs1374213G and CX3CR1rs9823718G or CX3CR1rs7631529A alleles had deregulated immune responses to Aspergillus conidia. These results, together with those from expression quantitative trait locus (eQTL) data browsers showing a strong correlation of the CX3CR1rs9823718G allele with lower levels of CX3CR1 mRNA in whole peripheral blood (P = 2.46 · 10-7) and primary monocytes (P = 4.31 · 10-7), highlight the role of the ARNT2 and CX3CR1 loci in modulating and predicting IA risk and provide new insights into the host immune mechanisms involved in IA development.
dc.description.sponsorshipWe thank Antonio Fernández-Montoya (Centro Regional de Transfuciones Sanguíneas Granada-Almería, Spain) and António Marques (Hospital de Braga, Braga, Portugal), who provided the buffy coat cells. We also thank Astellas Pharma Inc. and Consuelo González Moreno (AML survivor) for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We declare no conflict of interest. This study was supported by grants PI12/02688 and PI17/02276 from the Fondo de Investigaciones Sanitarias (Madrid, Spain), the program PIM2010EPA-00756 from ERA-NET PathoGenoMics (grant 0315900A), the Collaborative Research Center/Transregio 124 FungiNet, the Northern Portugal Regional Operational Program (grant NORTE 2020) under the Portugal 2020 Partnership Agreement through the European Regional Development Fund (FEDER) (grant NORTE-01-0145-FEDER-000013), and the Fundação para a Ciência e Tecnologia (FCT) (grants IF/00735/2014 to A.C. and SFRH/BPD/96176/2013 to C.C.).This study was also supported by Astellas Pharma Inc. and by a donation of Consuelo González Moreno, an acute myeloid leukemia survivor. M.J. and J. Sainz conceived the study and participated in its design and coordination. C.B.L. and J.M.S.-M. performed the genetic analyses. C.B.L., C.C., S.M.G., A.C., and J. Sainz performed in vitro functional analyses. J. Springer, M. Lackner, P.G.-S., J.B., J.S.-C., J.M.S.-M., R.R.-T., L.A.-F., M.A.L.-N., L.F., J.M.A., L. Pagano, L. Potenza, S.M.G., M. Luppi, C.S., M.C.-E., K.L., J.A.M., C.L.-F., H.E., L.V., J.L., A.C., M.J., J. Sainz, and the PCRAGA Study Group coordinated patient’s recruitment and provided the clinical data. M.A.-R. provided immuno-chromatin immunoprecipitation (immuno-ChIP) data from healthy controls. J. Sainz and M.M.-B. analyzed the data. M.J. and J. Sainz drafted the manuscript. All authors read and approved the final version of the manuscript.
dc.description.versionSi
dc.identifier.citationLupiañez CB, Martínez-Bueno M, Sánchez-Maldonado JM, Badiola J, Cunha C, Springer J, et al. Polymorphisms within the ARNT2 and CX3CR1 Genes Are Associated with the Risk of Developing Invasive Aspergillosis. Infect Immun. 2020 Mar 23;88(4):e00882-19.
dc.identifier.doi10.1128/IAI.00882-19
dc.identifier.essn1098-5522
dc.identifier.pmcPMC7093133
dc.identifier.pmid31964743
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093133/pdf
dc.identifier.unpaywallURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093133
dc.identifier.urihttp://hdl.handle.net/10668/14981
dc.issue.number4
dc.journal.titleInfection and immunity
dc.journal.titleabbreviationInfect Immun
dc.language.isoen
dc.organizationHospital Universitario San Cecilio
dc.organizationHospital Universitario Virgen de las Nieves
dc.organizationCentro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológica-GENYO
dc.organizationHospital Universitario San Cecilio
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.provenanceRealizada la curación de contenido 14/08/2024
dc.publisherAmerican Society for Microbiology
dc.pubmedtypeJournal Article
dc.relation.projectIDPI12/02688
dc.relation.projectIDPI17/02276
dc.relation.projectIDPIM2010EPA-00756
dc.relation.projectID0315900A
dc.relation.projectID0315900A
dc.relation.projectIDNORTE 2020
dc.relation.publisherversionhttps://journals.asm.org/doi/10.1128/IAI.00882-19?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
dc.rights.accessRightsRestricted Access
dc.subjectARNT2
dc.subjectCX3CR1
dc.subjectgenetic susceptibility
dc.subjecthost immunity
dc.subjectinvasive aspergillosis
dc.subject.decsAspergillus
dc.subject.decsAspergilosis pulmonar invasiva
dc.subject.decsEnfermedades hematológicas
dc.subject.decsEstudios de casos y controles
dc.subject.decsFactores de transcripción con motivo Hélice-Asa-Hélice Básico
dc.subject.decsGenotipo
dc.subject.decsHumanos
dc.subject.decsMedición de riesgo
dc.subject.decsPolimorfismo de nucleótido simple
dc.subject.decsPredisposición genética a la enfermedad
dc.subject.decsReceptor 1 de Quimiocinas CX3C
dc.subject.decsTranslocador nuclear del receptor de Aril Hidrocarburo
dc.subject.meshAryl Hydrocarbon Receptor Nuclear Translocator
dc.subject.meshAspergillus
dc.subject.meshBasic Helix-Loop-Helix Transcription Factors
dc.subject.meshCX3C Chemokine Receptor 1
dc.subject.meshCase-Control Studies
dc.subject.meshGenetic Predisposition to Disease
dc.subject.meshGenotype
dc.subject.meshHematologic Diseases
dc.subject.meshHumans
dc.subject.meshInvasive Pulmonary Aspergillosis
dc.subject.meshPolymorphism, Single Nucleotide
dc.subject.meshRisk Assessment
dc.titlePolymorphisms within the ARNT2 and CX3CR1 Genes Are Associated with the Risk of Developing Invasive Aspergillosis.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number88
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format